Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 9,067 full-time employees. Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The firm's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The firm's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The firm mainly operates its businesses in the domestic and overseas markets.
最新の財務諸表(Form-10K)によると、Livzon Pharmaceutical Group Inc.の総資産は$24,455で、純利益は$2,061です。
LVZPFの主要な財務比率は何ですか?
Livzon Pharmaceutical Group Inc.の流動比率は2.3、純利益率は17.44、1株当たり売上高は$12.83です。
Livzon Pharmaceutical Group Inc.の収益はセグメントまたは地域別にどのように分けられていますか?
Livzon Pharmaceutical Group Inc. の最大収益セグメントは Chemical Drug Preparations で、最新の利益発表における収益は 6,119,280,577 です。地域別に見ると、China が Livzon Pharmaceutical Group Inc. の主要市場であり、収益は 9,976,999,763 です。
Livzon Pharmaceutical Group Inc.は収益を上げていますか?
はい、最新の財務諸表によると、Livzon Pharmaceutical Group Inc.の純利益は$2,061です。
Livzon Pharmaceutical Group Inc.に負債はありますか?
はい、Livzon Pharmaceutical Group Inc.の負債は10,593です。
Livzon Pharmaceutical Group Inc.の発行済株式数は何株ですか?
Livzon Pharmaceutical Group Inc.の総発行済株式数は903.64株です。